Riboflavin and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Riboflavin (riboflavin (vitamin b2)) and Abilify (aripiprazole). Common drug interactions include glycosylated haemoglobin increased among females and cardiomyopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Riboflavin and Abilify. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Riboflavin?

Riboflavin has active ingredients of riboflavin (vitamin b2). It is often used in migraine. eHealthMe is studying from 2,869 Riboflavin users. Check the latest studies of Riboflavin.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

41 people who take Riboflavin and Abilify together, and have interactions are studied.

Riboflavin and Abilify drug interactions.

What are the common drug interactions of Riboflavin and Abilify, by gender? *:

female:

Glycosylated haemoglobin increased
Haematocrit
Hypervolaemia (abnormally increased volume of blood)
Impaired work ability
Infusion site discolouration
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Knee arthroplasty
Loss of employment
Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
Oxygen saturation decreased

male:

Cardiomyopathy (weakening of the heart muscle)
Hepatic congestion (liver congestion)
Dermatillomania (skin picking disorders)
Dysphagia (a condition in which swallowing is difficult or painful)
Eating disorder
Emotional distress
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Injury
Lymphocyte count increased

What are the common drug interactions of Riboflavin and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Aggression
Anger
Diarrhoea
Nausea (feeling of having an urge to vomit)
Retching (strong involuntary effort to vomit)
Vomiting

20-29:

Dizziness
Electrolyte imbalance
Haematocrit
Hypervolaemia (abnormally increased volume of blood)
Impaired work ability
Infusion site discolouration
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Loss of employment
Oxygen saturation decreased
Panic attack

30-39:

Cardiomyopathy (weakening of the heart muscle)
Hepatic congestion (liver congestion)
Hepatic steatosis (fatty liver disease)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Dysphagia (a condition in which swallowing is difficult or painful)
Head injury
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Arthralgia (joint pain)
Bankruptcy
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)

40-49:

Anxiety
Arthralgia (joint pain)
Joint swelling
Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
Suicidal ideation

50-59:

Staphylococcal infection (an infection with staphylococcus bacteria)
Headache (pain in head)
Influenza
Infusion related reaction
Nausea (feeling of having an urge to vomit)
Alanine aminotransferase increased
Dyspnoea (difficult or laboured respiration)
Knee arthroplasty
Pneumonia
Productive cough

60+:

Diarrhoea
Dizziness
Neuropathy peripheral (surface nerve damage)
Peripheral swelling

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 14 people, 34.15%
Pain: 6 people, 14.63%
Post Laminectomy Syndrome: 5 people, 12.20%
Neuralgia (pain in one or more nerves): 5 people, 12.20%
Neck Pain: 5 people, 12.20%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 12.20%
Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back)): 5 people, 12.20%
High Blood Pressure: 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Riboflavin and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously